Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gonorrhea
Biotech
Merck bags options on Evaxion's AI-designed vaccine candidates
Merck dangled more than $1 billion in milestones for options on preclinical prospects against gonorrhea and an undisclosed infectious agent.
Nick Paul Taylor
Sep 26, 2024 7:30am
GSK antibiotic shows potential in gonorrhea ahead of UTI filing
Feb 26, 2024 7:32am
‘Potential game changer’ gonorrhea antibiotic meets standard
Nov 2, 2023 11:20am